Skip to main content
Top
Published in: Virology Journal 1/2006

Open Access 01-12-2006 | Research

Serendipitous identification of natural Intergenotypic recombinants of hepatitis C in Ireland

Authors: Isabelle Moreau, Susan Hegarty, John Levis, Patrick Sheehy, Orla Crosbie, Elizabeth Kenny-Walsh, Liam J Fanning

Published in: Virology Journal | Issue 1/2006

Login to get access

Abstract

Background

Recombination between hepatitis C single stranded RNA viruses is a rare event. Natural viable intragenotypic and intergenotypic recombinants between 1b-1a, 1a-1c and 2k-1b, 2i-6p, respectively, have been reported. Diagnostically recombinants represent an intriguing challenge. Hepatitis C genotype is defined by interrogation of the sequence composition of the 5' untranslated region [5'UTR]. Occasionally, ambiguous specimens require further investigation of the genome, usually by interrogation of the NS5B region. The original purpose of this study was to confirm the existence of a suspected mixed genotype infection of genotypes 2 and 4 by clonal analysis at the NS5B region of the genome in two specimens from two separate individuals. This initial identification of genotype was based on analysis of the 5'UTR of the genome by reverse line probe hybridisation [RLPH].

Results

The original diagnosis of a mixed genotype infection was not confirmed by clonal analysis of the NS5B region of the genome. The phylogenetic analysis indicated that both specimens were natural intergenotypic recombinant forms of HCV. The recombination was between genotypes 2k and 1b for both specimens. The recombination break point was identified as occurring within the NS2 region of the genome.

Conclusion

The viral recombinants identified here resemble the recombinant form originally identified in Russia. The RLPH pattern observed in this study may be a signature indicative of this particular type of intergenotype recombinant of hepatitis C meriting clonal analysis of NS2.
Appendix
Available only for authorised users
Literature
1.
go back to reference The Global Burden of Hepatitis C Working Group: Global Burden of Disease (GBD) for Hepatitis C. J Clin Pharmacol 2004,44(1):20-29. 10.1177/0091270003258669CrossRef The Global Burden of Hepatitis C Working Group: Global Burden of Disease (GBD) for Hepatitis C. J Clin Pharmacol 2004,44(1):20-29. 10.1177/0091270003258669CrossRef
2.
go back to reference Kenny-Walsh E: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999,340(16):1228-1233. 10.1056/NEJM199904223401602CrossRefPubMed Kenny-Walsh E: Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999,340(16):1228-1233. 10.1056/NEJM199904223401602CrossRefPubMed
3.
go back to reference Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL: Protection against persistence of hepatitis C. Lancet 2002,359(9316):1478-1483. 10.1016/S0140-6736(02)08435-0CrossRefPubMed Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL: Protection against persistence of hepatitis C. Lancet 2002,359(9316):1478-1483. 10.1016/S0140-6736(02)08435-0CrossRefPubMed
4.
go back to reference Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993,74(Pt 11):2391-2399.CrossRefPubMed Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993,74(Pt 11):2391-2399.CrossRefPubMed
5.
go back to reference Jean-Michel Pawlotsky: Therapy of hepatitis C: From empiricism to eradication. Hepatology 2006,43(S1):S207-S220. 10.1002/hep.21064CrossRef Jean-Michel Pawlotsky: Therapy of hepatitis C: From empiricism to eradication. Hepatology 2006,43(S1):S207-S220. 10.1002/hep.21064CrossRef
6.
go back to reference Herrine S, Rossi S, Navarro V: Management of patients with chronic hepatitis C infection. Clinical and Experimental Medicine 2006,6(1):20-26. 10.1007/s10238-006-0089-4CrossRefPubMed Herrine S, Rossi S, Navarro V: Management of patients with chronic hepatitis C infection. Clinical and Experimental Medicine 2006,6(1):20-26. 10.1007/s10238-006-0089-4CrossRefPubMed
7.
go back to reference Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, et al.: Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection. N Engl J Med 2002,347(13):975-982. 10.1056/NEJMoa020047CrossRefPubMed Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, et al.: Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection. N Engl J Med 2002,347(13):975-982. 10.1056/NEJMoa020047CrossRefPubMed
8.
go back to reference Halfon P, Trimoulet P, Bourliere M, Khiri H, de Ledinghen V, Couzigou P, Feryn JM, Alcaraz P, Renou C, Fleury HJA, et al.: Hepatitis C Virus Genotyping Based on 5' Noncoding Sequence Analysis (Trugene). J Clin Microbiol 2001,39(5):1771-1773. 10.1128/JCM.39.5.1771-1773.2001PubMedCentralCrossRefPubMed Halfon P, Trimoulet P, Bourliere M, Khiri H, de Ledinghen V, Couzigou P, Feryn JM, Alcaraz P, Renou C, Fleury HJA, et al.: Hepatitis C Virus Genotyping Based on 5' Noncoding Sequence Analysis (Trugene). J Clin Microbiol 2001,39(5):1771-1773. 10.1128/JCM.39.5.1771-1773.2001PubMedCentralCrossRefPubMed
9.
go back to reference Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, et al.: Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. Journal of Viral Hepatitis 2005,12(4):405-413. 10.1111/j.1365-2893.2005.00605.xCrossRefPubMed Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, et al.: Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. Journal of Viral Hepatitis 2005,12(4):405-413. 10.1111/j.1365-2893.2005.00605.xCrossRefPubMed
10.
go back to reference Noppornpanth S, Sablon E, De Nys K, Lien TX, Brouwer J, Van Brussel M, Smits SL, Poovorawan Y, Osterhaus ADME, Haagmans BL: Genotyping Hepatitis C Viruses from South East Asia using a Novel Line Probe Assay That Simultaneously Detects 5'UTR and Core Regions. J Clin Microbiol 2006, JCM.01122-01106. Noppornpanth S, Sablon E, De Nys K, Lien TX, Brouwer J, Van Brussel M, Smits SL, Poovorawan Y, Osterhaus ADME, Haagmans BL: Genotyping Hepatitis C Viruses from South East Asia using a Novel Line Probe Assay That Simultaneously Detects 5'UTR and Core Regions. J Clin Microbiol 2006, JCM.01122-01106.
12.
go back to reference Kalinina O, Norder H, Mukomolov S, Magnius LO: A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002,76(8):4034-4043. 10.1128/JVI.76.8.4034-4043.2002PubMedCentralCrossRefPubMed Kalinina O, Norder H, Mukomolov S, Magnius LO: A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002,76(8):4034-4043. 10.1128/JVI.76.8.4034-4043.2002PubMedCentralCrossRefPubMed
13.
go back to reference Felsenstein J: Phylogeny Inference Package. University of Washington, Seattle. USA. 1995. Felsenstein J: Phylogeny Inference Package. University of Washington, Seattle. USA. 1995.
15.
go back to reference Kalinina O, Norder H, Magnius LO: Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol 2004,85(7):1853-1857. 10.1099/vir.0.79984-0CrossRefPubMed Kalinina O, Norder H, Magnius LO: Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol 2004,85(7):1853-1857. 10.1099/vir.0.79984-0CrossRefPubMed
16.
go back to reference Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL: Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006,80(15):7569-7577. 10.1128/JVI.00312-06PubMedCentralCrossRefPubMed Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL: Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006,80(15):7569-7577. 10.1128/JVI.00312-06PubMedCentralCrossRefPubMed
17.
18.
go back to reference Kuiken C, Yusim K, Boykin L, Richardson R: The Los Alamos hepatitis C sequence database. Bioinformatics 2005,21(3):379-384. 10.1093/bioinformatics/bth485CrossRefPubMed Kuiken C, Yusim K, Boykin L, Richardson R: The Los Alamos hepatitis C sequence database. Bioinformatics 2005,21(3):379-384. 10.1093/bioinformatics/bth485CrossRefPubMed
19.
go back to reference Fleury HJ, Toni T, Lan NT, Hung PV, Deshpande A, Recordon-Pinson P, Boucher S, Lazaro E, Jauvin V, Lavignolle-Aurillac V, et al.: Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data. AIDS Res Hum Retroviruses 2006,22(4):357-366. 10.1089/aid.2006.22.357CrossRefPubMed Fleury HJ, Toni T, Lan NT, Hung PV, Deshpande A, Recordon-Pinson P, Boucher S, Lazaro E, Jauvin V, Lavignolle-Aurillac V, et al.: Susceptibility to antiretroviral drugs of CRF01_AE, CRF02_AG, and subtype C viruses from untreated patients of Africa and Asia: comparative genotypic and phenotypic data. AIDS Res Hum Retroviruses 2006,22(4):357-366. 10.1089/aid.2006.22.357CrossRefPubMed
20.
go back to reference Fanning L, Kenny E, Sheehan M, Cannon B, Whelton M, O'Connell J, Collins JK, Shanahan F: Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology 1999,29(3):904-907. 10.1002/hep.510290310CrossRefPubMed Fanning L, Kenny E, Sheehan M, Cannon B, Whelton M, O'Connell J, Collins JK, Shanahan F: Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology 1999,29(3):904-907. 10.1002/hep.510290310CrossRefPubMed
21.
go back to reference Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, et al.: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992,258(5079):135-140. 10.1126/science.1279801CrossRefPubMed Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, et al.: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992,258(5079):135-140. 10.1126/science.1279801CrossRefPubMed
22.
go back to reference Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, Bentata M, Jarrousse B, Lortholary O, Pallier C, et al.: Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 2001,82(Pt 5):1001-1012.CrossRefPubMed Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, Bentata M, Jarrousse B, Lortholary O, Pallier C, et al.: Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol 2001,82(Pt 5):1001-1012.CrossRefPubMed
23.
go back to reference Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J: Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 2003,109(2):187-193. 10.1016/S0166-0934(03)00070-3CrossRefPubMed Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J: Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 2003,109(2):187-193. 10.1016/S0166-0934(03)00070-3CrossRefPubMed
Metadata
Title
Serendipitous identification of natural Intergenotypic recombinants of hepatitis C in Ireland
Authors
Isabelle Moreau
Susan Hegarty
John Levis
Patrick Sheehy
Orla Crosbie
Elizabeth Kenny-Walsh
Liam J Fanning
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2006
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-3-95

Other articles of this Issue 1/2006

Virology Journal 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine